Propionic Acid

Propionic Acid

SCHEMBL4171736

CCC(=O)O.O=C(CBr)c1ccc2[nH]c(=O)c3[nH]ccc3c2c1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.41
KDM4E B2RXH2 5/20 0.35
ALDH1A1 P00352 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HCRTR1 O43613 2/20 0.35
MAPT P10636 2/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GNG2 P59768 1/20 0.35
GNB1 P62873 1/20 0.35
APEX1 P27695 1/20 0.35
PTPN1 P18031 2/20 0.35
GSK3B P49841 2/20 0.35
HPGD P15428 3/20 0.34
HSD17B10 Q99714 2/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34
THRB P10828 1/20 0.34
GRIK1 P39086 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4719928 0.93 PARP1 (0.46) PARP1KDM4EALDH1A1MEN1KMT2A
Propionic Acid SCHEMBL4161934 0.88 KDM4E (0.41) PARP1KDM4EALDH1A1MEN1KMT2A
Propionic Acid SCHEMBL4169905 0.87 KIF11 (0.45) PARP1KDM4EALDH1A1MEN1KMT2A
Propionic Acid SCHEMBL4159927 0.84 ALDH1A1 (0.40) KDM4EALDH1A1MEN1KMT2AHCRTR1
Propionic Acid SCHEMBL4155436 0.83 PIM3 (0.49) KDM4EALDH1A1MEN1KMT2AMAPT
Propionic Acid SCHEMBL4165125 0.81 PARP1 (0.47) PARP1KDM4EALDH1A1MEN1KMT2A
Propionic Acid SCHEMBL4160624 0.81 MPO (0.43) KDM4EGSK3BMAPK1
Propionic Acid SCHEMBL4169911 0.81 GABRA1 (0.41) PARP1KDM4EALDH1A1MEN1KMT2A
Propionic Acid SCHEMBL4162940 0.80 ALDH1A1 (0.53) PARP1KDM4EALDH1A1MEN1KMT2A
Propionic Acid SCHEMBL4153840 0.80 PIM1 (0.44) KDM4EALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PARP1 628/4885KDM4E 1970/4885ALDH1A1 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.